Halallan thoyibban is a powerful product label that enhances the wholesomeness, quality, and integrity of any product. Halal is not just limited to eating and drinking but also encompasses earning a livelihood, dress code, and interactions with others. Therefore, the concept of halal extends beyond religious practices. Halal products promise safety, hygiene, quality, and efficacy as products have to meet the highest quality standards and rigorous regulations. Biotechnology has emerged as a new frontier in pharmaceuticals, leading to significant developments such as the production of halal insulin, halal vaccines, and halal-certified gelatin. Innovations in the production of insulin, now ensure that it is derived from halal sources, providing essential treatment for diabetes while adhering to dietary and religious standards. Advancements in vaccine development are ensuring that vaccines are produced without any components derived from non-halal sources, making them accessible to Muslim populations. The use of halal-certified gelatin in pharmaceuticals has expanded, allowing consumers to trust the integrity of these ingredients. Growing with the latest advances in pharmaceuticals, many questions arise on whether these modern pharmaceuticals still abide by the promises of Halallan thoyibban and do what is called permissible and legitimate and is not contrary to God’s instructions. It is imperative to address the unspoken issues related to halal medicine as they have the potential to cause significant problems in the future. This review discusses the latest advancement of biotechnology in pharmaceuticals and how these pharmaceutical products comply with the promises of Halallan thoyibban. As there is a growing need for halal pharmaceuticals globally, this venture must explicitly ensure that pharmaceutical products meet the highest standards of safety, efficacy, and quality.